A 61-year-old non-smoking woman presented with low-grade fever of 1 year duration, which had remained undiagnosed after several first-line investigations. Intermittent non-productive cough and arthromyalgias were the only relevant complaints on history taking. Clinical examination was otherwise unremarkable. Laboratory findings only revealed increased C-reactive protein at 5 mg/dL. Of note, renal function tests, urinalysis and autoimmune serum tests (ANCA, FAN and anti-GBM antibodies) as well as serum and urinary calcium levels were all normal. Chest X-ray showed no hilar lymphadenopathy or significant parenchymal abnormality. F-18 fluorodeoxyglucose (FDG) PET/CT demonstrated intense tracer uptake not only in bilateral peripheral lung parenchyma ([Figure 1](#fig1){ref-type="fig"}---baseline, A1 and B1) but also in both kidneys ([Figure 1](#fig1){ref-type="fig"}---baseline, A2 and B2). Sarcoidosis was diagnosed by transbronchial lung biopsy with the presence of non-caseating epithelioid granuloma. Taking into account all these clinical elements, a kidney biopsy was deemed unethical. Three months after oral corticosteroid therapy (0.5 mg/kg/day methylprednisolone), a second F-18 FDG PET/CT showed a complete regression of both pathological lung ([Figure 1](#fig1){ref-type="fig"}---second scan, C3 and D3) and kidney foci, where only a physiological excretion of FDG was seen within the urinary tract ([Figure 1](#fig1){ref-type="fig"}---second scan, C4 and D4). \[Note that the bilateral kidneys hypertrophy related to the disease ([Figure 1](#fig1){ref-type="fig"}---baseline, A2 and B2) also significantly decreased under treatment ([Figure 1](#fig1){ref-type="fig"}---second scan, C4 and D4)\].
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Renal manifestations of sarcoidosis are most commonly due to hypercalciuria (with or without hypercalcaemia) and granulomatous interstitial nephritis (GIN) \[[@ref1]\]. Glomerular disease, urinary tract involvement by retroperitoneal lymph node, and renal masses, the so-called pseudotumoral renal sarcoid, are rarer events \[[@ref2]\]. Patients presenting with GIN have most often clear evidence of diffuse active sarcoidosis, although some patients present with isolated elevation of plasma creatinine level, and no or only minimal extra-renal manifestations. We report here an unusual presentation in the form of a clinically and biologically silent renal involvement in a patient with biopsy-proven pulmonary sarcoidosis, which was only revealed by FDG PET/CT. As mentioned for various other non-thoracic manifestations of the disease, F-18 FDG PET/CT is a promising non-invasive tool in this disorder, not only to assess the presence of active unexpected organ involvement, but also to monitor the response to glucocorticoid therapy \[[@ref3]\].
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